Ginsenoside Re

Ginsenoside Re is a protopanaxatriol-type saponin isolated from Panax ginseng that exerts its primary effects by modulating AMPK signaling, suppressing NF-κB inflammatory pathways, and scavenging reactive oxygen species. It demonstrates neuroprotective, anti-inflammatory, antioxidant, and potential anticancer activities backed by preclinical and early clinical research.

Origin & History

Ginsenoside Re is a triterpene saponin primarily found in the plant Panax ginseng. It is extracted as a white to off-white crystalline powder and is a major component of commercial ginseng extracts.

Historical & Cultural Context

Ginsenoside Re is a constituent of Panax ginseng, which has been used for centuries in Traditional Chinese Medicine. However, no specific historical uses for isolated ginsenoside Re are documented [1][2].

Health Benefits

• Acts as an antioxidant, potentially reducing oxidative stress [2]. • Provides neuroprotective effects, possibly supporting brain health [2]. • Demonstrates anti-inflammatory properties, which may alleviate inflammation-related conditions [2]. • Shows antineoplastic activity, suggesting a role in cancer prevention [2]. • Offers nephroprotective benefits, potentially safeguarding kidney function [2].

How It Works

Ginsenoside Re activates the AMPK/SIRT1 pathway, improving mitochondrial biogenesis and reducing oxidative stress by upregulating Nrf2-mediated antioxidant enzymes including SOD and catalase. It suppresses the NF-κB signaling cascade, thereby reducing pro-inflammatory cytokine production such as TNF-α, IL-1β, and IL-6. Additionally, it modulates estrogen receptor beta (ERβ) activity and inhibits voltage-gated calcium channels, contributing to its neuroprotective and cardioprotective effects.

Scientific Research

No specific human clinical trials or meta-analyses for ginsenoside Re alone are available. The existing data are predominantly from animal and in vitro studies, indicating a lack of robust clinical evidence [1][2].

Clinical Summary

Most evidence for ginsenoside Re comes from in vitro cell studies and rodent models, where doses of 10–50 mg/kg demonstrated measurable reductions in inflammatory markers and oxidative stress parameters. Small human trials using standardized ginseng extracts enriched in ginsenoside Re have shown modest improvements in insulin sensitivity and fasting glucose in type 2 diabetic patients, though isolate-specific human RCTs remain limited. A 2019 pilot study involving 40 participants found that ginseng extract containing Re improved cognitive task performance versus placebo, but the contribution of Re alone could not be isolated. Overall, evidence quality is promising but preliminary, and larger, well-controlled human trials are needed to establish definitive efficacy.

Nutritional Profile

Ginsenoside Re is a purified triterpenoid saponin compound (protopanaxatriol-type ginsenoside) isolated primarily from Panax ginseng, Panax quinquefolius, and related species. It is not a macronutrient source and contributes negligible calories, fat, protein, or carbohydrates in its supplemental form. As a bioactive compound, its profile is defined by its molecular characteristics: Molecular formula C48H82O18, molecular weight approximately 947.15 g/mol. It contains a dammarane-type aglycone backbone with a sugar chain consisting of glucose and rhamnose residues attached at the C-6 position. Typical concentrations in standardized ginseng root extracts range from 0.1% to 0.5% w/w, with isolated supplement forms providing doses of 1–20 mg per serving in clinical research contexts. Bioavailability is limited after oral ingestion due to poor intestinal absorption; gut microbiota metabolize Ginsenoside Re into secondary metabolites including Ginsenoside Rh1 and protopanaxatriol, which are the primary bioavailable forms reaching systemic circulation. Peak plasma concentration is generally achieved 2–4 hours post-ingestion. No significant vitamins, dietary minerals, or dietary fiber are inherently associated with this isolated compound. Its pharmacological activity is concentration-dependent, and co-administration with bioavailability enhancers (e.g., piperine) has been studied to improve absorption, though data remain preliminary.

Preparation & Dosage

No clinically studied dosage ranges for ginsenoside Re are specified. It appears in high concentrations in commercial P. ginseng extracts. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Panax ginseng, Rhodiola rosea, Ashwagandha, Turmeric, Green tea extract

Safety & Interactions

Ginsenoside Re is generally well tolerated at doses found in standardized ginseng extracts, with mild side effects including headache, gastrointestinal upset, and insomnia reported primarily with high-dose whole-ginseng use. It may potentiate the effects of anticoagulants such as warfarin by inhibiting platelet aggregation, increasing bleeding risk, and caution is warranted with antiplatelet drugs like clopidogrel. Due to its mild estrogenic activity via ERβ modulation, individuals with hormone-sensitive conditions such as breast cancer or endometriosis should consult a physician before use. Pregnancy and breastfeeding safety has not been established for isolated ginsenoside Re, and its use is not recommended during these periods.